Literature DB >> 10412535

[Intramedullary cysticercosis: case report].

F L Dantas1, W J Fagundes-Pereyra, C T De Souza, M G Vega, A A De Souza.   

Abstract

Cysticercosis is the most ordinary parasitary disease involving the nervous system. The involvement of the spine is rare, ranging from 0.7% to 5.8%, and the intramedullary incidence is rather uncommon. We report the case of a 52-year-old female patient with intramedullary cysticercosis at the C4-C5 level, treated at the Neurology and Neurosurgery Service of Santa Casa de Belo Horizonte. The patient was operated with the complete exeresis of the lesion and had a good outcome. Forty-five cases of intramedullary cysticercosis were found in the literature review. We conclude that although it is a rare pathology, intramedullary cysticercosis should be included in the differential diagnosis of intramedullary lesions, mainly in cases of patients with previous diagnosis for neurocysticercosis and also of those who live in endemic areas.

Entities:  

Mesh:

Year:  1999        PMID: 10412535     DOI: 10.1590/s0004-282x1999000200023

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

Review 1.  Spinal Taenia solium cysticercosis in Mexican and Indian patients: a comparison of 30-year experience in two neurological referral centers and review of literature.

Authors:  Graciela Cárdenas; Erik Guevara-Silva; Felipe Romero; Yair Ugalde; Cecilia Bonnet; Agnes Fleury; Edda Sciutto; Caris Maroni Nunes; José Luis Soto-Hernández; Susarla Krishna Shankar; Anita Mahadevan
Journal:  Eur Spine J       Date:  2015-10-16       Impact factor: 3.134

2.  Isolated intramedullary spinal cord cysticercosis.

Authors:  Zeeshan Qazi; Bal Krishna Ojha; Anil Chandra; Sunil Kumar Singh; Chhitij Srivastava; Tushar B Patil
Journal:  J Neurosci Rural Pract       Date:  2014-11

3.  Spinal cysticercosis: a rare cause of myelopathy.

Authors:  Chenlong Yang; Tie Liu; Jian Wu; Jingcheng Xie; Tao Yu; Wenqing Jia; Jun Yang; Yulun Xu
Journal:  BMC Neurol       Date:  2022-02-22       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.